{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T18:36:13Z","timestamp":1791657373720,"version":"4.3.4"},"reference-count":81,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jtha.2024.01.017","type":"journal-article","created":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T01:04:20Z","timestamp":1706835860000},"page":"1304-1312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Reducing the risk of atherosclerotic cardiovascular disease in people with hemophilia: the importance of primary prevention"],"prefix":"10.1016","volume":"22","author":[{"given":"Caroline","family":"Dix","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerry","family":"Dolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverley J.","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2024.01.017_bib1","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2141.1985.tb07353.x","article-title":"Life expectancy of Swedish haemophiliacs, 1831-1980","volume":"59","author":"Larsson","year":"1985","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2024.01.017_bib2","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1538-7836.2006.01808.x","article-title":"Mortality and causes of death in patients with haemophilia, 1992-2001: a prospective cohort study","volume":"4","author":"Plug","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.01.017_bib3","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1182\/blood-2006-10-050435","article-title":"Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV","volume":"110","author":"Darby","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.01.017_bib8","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1111\/jth.12698","article-title":"Thrombosis: a major contributor to the global disease burden","volume":"12","year":"2014","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.01.017_bib9","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/jth.15189","article-title":"Mortality in congenital haemophilia A \u2013 a systematic literature review","volume":"19","author":"Hay","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.01.017_bib10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/CRD.0000000000000045","article-title":"Consensus review of the treatment of cardiovascular disease in people with haemophilia A and B","volume":"23","author":"Ferraris","year":"2015","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.jtha.2024.01.017_bib11","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1161\/hc3501.094232","article-title":"Decreased coagulability has no clinically relevant effect on atherogenesis: observations in individuals with a hereditary bleeding tendency","volume":"104","author":"Sr\u00e1mek","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2024.01.017_bib12","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1538-7836.2011.04499.x","article-title":"Factor VIII deficiency does not protect against atherosclerosis","volume":"10","author":"Biere-Rafi","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.01.017_bib13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1538-7836.2011.04514.x","article-title":"Coronary artery calcification score and carotid intima-media thickness in patients with haemophilia","volume":"10","author":"Zwiers","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.01.017_bib14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/ajh.20339","article-title":"Prevalence and risk factors for heart disease among males with haemophilia","volume":"79","author":"Kulkarni","year":"2005","journal-title":"Am J Haematol"},{"key":"10.1016\/j.jtha.2024.01.017_bib15","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1182\/blood-2013-11-453159","article-title":"Cardiovascular risk in patients with haemophilia","volume":"123","author":"Kamphiusen","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.01.017_bib16","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/j.1365-2516.2011.02501.x","article-title":"Atherosclerotic heart disease: prevalence and risk factors in hospitalised men with haemophilia A","volume":"17","author":"Ragni","year":"2011","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2024.01.017_bib17","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2141.1990.tb07793.x","article-title":"Haemophilia protects against ischaemic heart disease: a study of risk factors","volume":"75","author":"Rosendaal","year":"1990","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2024.01.017_bib18","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/j.1365-2516.2009.02030.x","article-title":"Comorbidities and bleeding pattern in elderly haemophilia A patients","volume":"15","author":"Miesbach","year":"2009","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2024.01.017_bib19","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1160\/TH10-07-0460","article-title":"Cardiovascular risk assessment in haemophilia patients","volume":"105","author":"Biere-Rafi","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.01.017_bib20","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1161\/HYPERTENSIONAHA.113.01174","article-title":"Prevalence and risk factors for hypertension in haemophilia","volume":"62","author":"Von Drygalski","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.jtha.2024.01.017_bib21","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1182\/bloodadvances.2018018226","article-title":"A\u00a0cross-sectional analysis of cardiovascular disease in the hemophilia population","volume":"2","author":"Sood","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2024.01.017_bib22","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/hae.12847","article-title":"Hypertension, haematuria and renal functioning in haemophilia \u2013 a cross-sectional study in Europe","volume":"22","author":"Holme","year":"2016","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2024.01.017_bib23","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000019339","article-title":"Macroscopic hematuria as a risk factor for hypertension in ageing people with hemophilia and a family history of hypertension","volume":"99","author":"Qvigstad","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jtha.2024.01.017_bib24","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1160\/TH12-05-0332","article-title":"Unfavourable cardiovascular disease risk profiles in a cohort of Dutch and British haemophilia patients","volume":"109","author":"Fransen van de Putte","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.01.017_bib25","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1136\/bmj.332.7553.1302","article-title":"Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials","volume":"332","author":"Kearney","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.jtha.2024.01.017_bib26","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1365-2516.2010.02463.x","article-title":"Prevalence and risk factors of cardiovascular disease (CVD) events among patients with haemophilia: experience of a single haemophilia treatment centre in the United States (US)","volume":"174","author":"Sharathkumar","year":"2011","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2024.01.017_bib27","first-page":"207","article-title":"The effect of haemophilia and von Willebrand disease on arterial thrombosis: a systematic review","volume":"68","author":"Biere-Rafi","year":"2010","journal-title":"Neth J Med"},{"key":"10.1016\/j.jtha.2024.01.017_bib28","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/jth.13674","article-title":"Comparing thrombin generation in patients with hemophilia A and patients on vitamin K antagonists","volume":"15","author":"de Koning","year":"2017","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.01.017_bib29","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1538-7836.2011.04542.x","article-title":"Reduced cardiovascular mortality in haemophilia despite normal atherosclerotic load","volume":"10","author":"Makris","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.01.017_bib30","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/00002030-200402200-00020","article-title":"The impact of HIV on mortality rates in the complete UK haemophilia population","volume":"18","author":"Darby","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.jtha.2024.01.017_bib31","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2516.2012.02912.x","article-title":"Morbidity and mortality in ageing HIV-infected haemophilia patients","volume":"19","author":"Fransen van de Putte","year":"2013","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2024.01.017_bib32","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1161\/CIR.0000000000000695","article-title":"Characteristics, prevention and management of cardiovascular disease in people living with HIV: a scientific statement from the American heart association","volume":"140","author":"Feinstein","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2024.01.017_bib33","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1097\/QAD.0000000000001149","article-title":"Plasma IL-6 levels are independently associated with atherosclerosis and mortality in HIV-infected individuals on suppressive antiretroviral therapy","volume":"30","author":"Hsu","year":"2016","journal-title":"AIDS"},{"key":"10.1016\/j.jtha.2024.01.017_bib34","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1093\/infdis\/jix082","article-title":"Association of macrophage inflammation biomarkers with progression of subclinical carotid artery atherosclerosis in HIV-infected women and men","volume":"215","author":"Hanna","year":"2017","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jtha.2024.01.017_bib35","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000900","article-title":"Antithrombotic treatment in patients with haemophilia: an EHA-ISTH-EAHAD-ESO clinical practice guideline","volume":"7","author":"Schutgens","year":"2023","journal-title":"Hemasphere"},{"key":"10.1016\/j.jtha.2024.01.017_bib36","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1136\/bmj.38561.633345.8F","article-title":"Modelling the decline in coronary heart disease deaths in England and Wales, 1981-2000: comparing contributions from primary prevention and secondary prevention","volume":"17","author":"Unal","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.jtha.2024.01.017_bib37","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1161\/CIRCULATIONAHA.120.045851","article-title":"The expected 30-year benefits of early versus delayed primary prevention of cardiovascular disease by lipid lowering","volume":"142","author":"Pencina","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2024.01.017_bib38","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/S0140-6736(21)00590-0","article-title":"Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis","volume":"397","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2024.01.017_bib40","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1182\/bloodadvances.2021005260","article-title":"Reduced cardiovascular morbidity in patients with hemophilia: results of a 5-year multinational prospective study","volume":"6","author":"Van Der Valk","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2024.01.017_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hae.14046","article-title":"WFH Guidelines for the Management of Hemophilia panelists and co-authors. WFH guidelines for the management of haemophilia, 3rd edition","volume":"26","author":"Srivastava","year":"2020","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2024.01.017_bib42","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/hae.14641","article-title":"Promoting physical activity for people with haemophilia in the age of new treatments","volume":"28","author":"Matlary","year":"2022","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2024.01.017_bib43","first-page":"CD011180","article-title":"Exercise for haemophilia","volume":"12","author":"Strike","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jtha.2024.01.017_bib44","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/hae.14522","article-title":"Aerobic exercise in patients with haemophilia: a systematic review on safety, feasibility and health effects","volume":"28","author":"Tomschi","year":"2022","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2024.01.017_bib45","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3389\/fcvm.2018.00135","article-title":"Cardiovascular effects and benefits of exercise","volume":"5","author":"Nystoriak","year":"2018","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jtha.2024.01.017_bib46","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2024.01.017_bib47","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.amjmed.2011.10.023","article-title":"Salt and hypertension: is salt dietary reduction worth the effort?","volume":"125","author":"Frisoli","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.jtha.2024.01.017_bib48","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/MBC.0000000000000554","article-title":"The effect of Nordic walking on joint status, quality of life, physical ability, exercise capacity and pain in adult persons with haemophilia","volume":"27","author":"Salim","year":"2016","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jtha.2024.01.017_bib49","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1111\/hae.13764","article-title":"The effects of a six-week resistance, aerobic and combined exercises on the pro-inflammatory and anti-inflammatory markers in overweight patients with moderate haemophilia A: a randomised controlled trial","volume":"25","author":"Parhampour","year":"2019","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2024.01.017_bib50","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1007\/s11695-019-03831-6","article-title":"Korean Research Group for Endoscopic Management of Metabolic Disorder and Obesity. Comparative efficacy of bariatric surgery in the treatment of morbid obesity and diabetes mellitus: a systematic review and network meta-analysis","volume":"29","author":"Park","year":"2019","journal-title":"Obes Surg"},{"key":"10.1016\/j.jtha.2024.01.017_bib51","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2024.01.017_bib53","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1111\/hae.12926","article-title":"Bariatric surgery in haemophilia","volume":"22","author":"Yerrabothala","year":"2016","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2024.01.017_bib54","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1055\/s-0038-1668571","article-title":"First case of laparoscopic mini-gastric bypass for the treatment of morbid obesity in severe haemophilia A","volume":"39","author":"Plamper","year":"2019","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.jtha.2024.01.017_bib55","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1001\/jama.2019.10298","article-title":"Association of smoking cessation with subsequent risk of cardiovascular disease","volume":"322","author":"Duncan","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2024.01.017_bib56","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1161\/CIRCRESAHA.118.312782","article-title":"Statin toxicity","volume":"124","author":"Ward","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.jtha.2024.01.017_bib57","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-023085","article-title":"Statins for the primary prevention of cardiovascular disease: an overview of systematic reviews","volume":"9","author":"Byrne","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.jtha.2024.01.017_bib58","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1056\/NEJMoa0900241","article-title":"A\u00a0randomised trial of rosuvastatin in the prevention of venous thromboembolism","volume":"360","author":"Glynn","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2024.01.017_bib59","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1001\/jama.2022.12138","article-title":"Statin use for the primary prevention of cardiovascular disease in adults: updated evidence report and systematic review for the US preventative services task force","volume":"328","author":"Chou","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2024.01.017_bib60","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1001\/archinternmed.2011.32","article-title":"Effects of benefits and harms on older persons\u2019 willingness to take medication for primary cardiovascular prevention","volume":"171","author":"Fried","year":"2011","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jtha.2024.01.017_bib61","doi-asserted-by":"crossref","first-page":"o2939","DOI":"10.1136\/bmj.o2939","article-title":"Statin related muscle symptoms: is it time to move on","volume":"379","author":"Khan","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.jtha.2024.01.017_bib62","article-title":"Side effects of statin use and focus on rhabdomyolysis","volume":"12","author":"Polli","year":"2014","journal-title":"E-J Cardiol Pract"},{"key":"10.1016\/j.jtha.2024.01.017_bib63","article-title":"Risk of diabetes with statins","volume":"381","author":"Mansi","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.jtha.2024.01.017_bib64","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/S0140-6736(16)31357-5","article-title":"Interpretation of the evidence for the efficacy and safety of statin therapy","volume":"388","author":"Collins","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2024.01.017_bib65","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1093\/aje\/kwv255","article-title":"Statins and risk of bleeding: an analysis to evaluate possible bias due to prevalent users and healthy user aspects","volume":"183","author":"van Rein","year":"2016","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jtha.2024.01.017_bib66","article-title":"Concurrent use of statins decreases major bleeding and intracerebral haemorrhage in non-valvular atrial fibrillation patients taking direct oral anticoagulants \u2013 a nationwide cohort study","volume":"9","author":"Wu","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jtha.2024.01.017_bib67","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMoa061894","article-title":"Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High-dose atorvastatin after stroke or transient ischaemic attack","volume":"355","author":"Amarenco","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2024.01.017_bib68","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(04)15690-0","article-title":"Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions","volume":"363","author":"Collins","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2024.01.017_bib69","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1161\/CIRCULATIONAHA.111.055269","article-title":"Statins and intracerebral hemorrhage: collaborative systematic review and meta-analysis","volume":"124","author":"Hackam","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2024.01.017_bib70","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1161\/STROKEAHA.119.027301","article-title":"Statins and risk of intracerebral hemorrhage in individuals with a history of stroke","volume":"51","author":"Ribe","year":"2020","journal-title":"Stroke"},{"key":"10.1016\/j.jtha.2024.01.017_bib71","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1161\/CIRCULATIONAHA.112.145334","article-title":"Statins as antithrombotic drugs","volume":"127","author":"Violi","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2024.01.017_bib72","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1182\/blood-2013-04-491845","article-title":"Antithrombotic actions of statins involve PECAM-1 signaling","volume":"122","author":"Moraes","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.01.017_bib73","first-page":"287","article-title":"Anti-inflammatory and antithrombotic effects of statins in the management of coronary artery disease","volume":"48","author":"Undas","year":"2002","journal-title":"Clin Lab"},{"key":"10.1016\/j.jtha.2024.01.017_bib74","doi-asserted-by":"crossref","DOI":"10.20452\/pamw.16208","article-title":"Statins in prevention of thromboembolic events: from seminal studies to recent advances","volume":"132","author":"Undas","year":"2022","journal-title":"Pol Arch Intern Med"},{"key":"10.1016\/j.jtha.2024.01.017_bib75","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1056\/NEJMoa2215024","article-title":"Bempedoic acid and cardiovascular outcomes in statin-intolerant patients","volume":"388","author":"Nissen","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2024.01.017_bib76","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"FOURIER Steering Committee and Investigators. Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"4","author":"Sabatine","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2024.01.017_bib77","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa1815359","article-title":"Polypill for cardiovascular disease prevention in an underserved population","volume":"381","author":"Munoz","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2024.01.017_bib78","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0140-6736(19)31791-X","article-title":"Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases: a pragmatic cluster randomised controlled trial","volume":"394","author":"Roshandel","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2024.01.017_bib79","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/QAI.0b013e31828a292c","article-title":"Aspirin attenuates platelet activation and immune activation in HIV-1 infected subjects on antiretroviral therapy: a pilot study","volume":"63","author":"O\u2019Brien","year":"2013","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jtha.2024.01.017_bib80","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1055\/s-0040-1718410","article-title":"Long-term antithrombotic treatments prescribed for cardiovascular diseases in patients with haemophilia: results from the French registry","volume":"121","author":"Guillet","year":"2021","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.01.017_bib81","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.3324\/haematol.2022.282407","article-title":"How we manage cardiovascular disease in patients with haemophilia","volume":"108","author":"Franchini","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2024.01.017_bib82","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/bjh.18085","article-title":"Cardiovascular disease in hereditary haemophilia: the challenges of longevity","volume":"197","author":"Shapiro","year":"2022","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2024.01.017_bib83","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1182\/blood-2015-12-635094","article-title":"How I treat patients with inherited bleeding disorders who need anticoagulant therapy","volume":"128","author":"Martin","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.01.017_bib84","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1182\/blood-2016-07-727032","article-title":"New concepts for anticoagulant therapy in persons with haemophilia","volume":"128","author":"Schutgens","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.01.017_bib85","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s12185-021-03276-7","article-title":"Comparisons of global coagulation potential and bleeding episodes in emicizumab-treated haemophilia A patients and mild haemophilia A patients","volume":"115","author":"Nakajima","year":"2022","journal-title":"Int J Haematol"},{"key":"10.1016\/j.jtha.2024.01.017_bib86","doi-asserted-by":"crossref","DOI":"10.1177\/10760296221082992","article-title":"Regression analysis to estimate the factor VIII activity of patients with hemophilia A without inhibitor who received emicizumab therapy","volume":"28","author":"Hatayama","year":"2022","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.jtha.2024.01.017_bib87","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/hae.14359","article-title":"Determining the approximate factor VIII level of patients with severe haemophilia A on emicizumab using in\u00a0vivo global haemostasis assays","volume":"27","author":"Kizilocak","year":"2021","journal-title":"Haemophilia"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624000588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624000588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T13:26:35Z","timestamp":1746105995000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783624000588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":81,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1538783624000588"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2024.01.017","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reducing the risk of atherosclerotic cardiovascular disease in people with hemophilia: the importance of primary prevention","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2024.01.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}